| 0 |
ANOGENITAL LICHEN PLANUS |
1 |
0.0667 |
| 1 |
CONGENITAL MYASTHENIC SYNDROME |
1 |
0.0476 |
| 2 |
MICROSLEEP |
1 |
0.0250 |
| 3 |
DERMAL ABSORPTION INCREASED |
1 |
0.0244 |
| 4 |
URINE CALCIUM |
1 |
0.0189 |
| 5 |
POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE II |
1 |
0.0185 |
| 6 |
SLEEP SEX |
1 |
0.0167 |
| 7 |
PLASMA CELLS INCREASED |
1 |
0.0137 |
| 8 |
FIGHT IN SCHOOL |
1 |
0.0135 |
| 9 |
DISRUPTIVE MOOD DYSREGULATION DISORDER |
1 |
0.0135 |
| 10 |
URINE AMPHETAMINE POSITIVE |
4 |
0.0122 |
| 11 |
HUMAN BITE |
1 |
0.0120 |
| 12 |
PULMONARY HISTOPLASMOSIS |
1 |
0.0100 |
| 13 |
SKIN ODOUR ABNORMAL |
36 |
0.0091 |
| 14 |
SEPARATION ANXIETY DISORDER |
1 |
0.0084 |
| 15 |
SCHIZOPHRENIA, PARANOID TYPE |
3 |
0.0083 |
| 16 |
BRIEF RESOLVED UNEXPLAINED EVENT |
1 |
0.0076 |
| 17 |
SPECIFIC GRAVITY URINE INCREASED |
1 |
0.0075 |
| 18 |
TONSILLOLITH |
1 |
0.0071 |
| 19 |
HYPERACTIVE PHARYNGEAL REFLEX |
1 |
0.0069 |
| 20 |
AMPHETAMINES POSITIVE |
5 |
0.0067 |
| 21 |
CYCLOTHYMIC DISORDER |
1 |
0.0061 |
| 22 |
CENTRAL NERVOUS SYSTEM STIMULATION |
1 |
0.0056 |
| 23 |
OPPOSITIONAL DEFIANT DISORDER |
2 |
0.0051 |
| 24 |
DRUG WITHDRAWAL HEADACHE |
2 |
0.0048 |
| 25 |
EXPOSURE VIA INHALATION |
1 |
0.0046 |
| 26 |
PRODUCT CONTAMINATION CHEMICAL |
1 |
0.0046 |
| 27 |
SUBSTANCE ABUSER |
1 |
0.0044 |
| 28 |
CREST SYNDROME |
1 |
0.0042 |
| 29 |
AUTOPHOBIA |
1 |
0.0039 |
| 30 |
ONYCHOPHAGIA |
1 |
0.0036 |
| 31 |
MERYCISM |
1 |
0.0035 |
| 32 |
REGRESSIVE BEHAVIOUR |
1 |
0.0034 |
| 33 |
THYROIDITIS SUBACUTE |
1 |
0.0034 |
| 34 |
SLEEP PARALYSIS |
5 |
0.0034 |
| 35 |
MIGRAINE WITHOUT AURA |
1 |
0.0033 |
| 36 |
DEFIANT BEHAVIOUR |
1 |
0.0032 |
| 37 |
VASCULAR COMPRESSION |
1 |
0.0032 |
| 38 |
SEASONAL AFFECTIVE DISORDER |
1 |
0.0032 |
| 39 |
PRESSURE OF SPEECH |
2 |
0.0031 |
| 40 |
OXYGEN SATURATION INCREASED |
1 |
0.0029 |
| 41 |
PHYSICAL EXAMINATION ABNORMAL |
1 |
0.0026 |
| 42 |
SUICIDE THREAT |
1 |
0.0026 |
| 43 |
DISEASE RISK FACTOR |
1 |
0.0025 |
| 44 |
REACTION TO COLOURING |
1 |
0.0024 |
| 45 |
SUICIDAL BEHAVIOUR |
10 |
0.0024 |
| 46 |
SELF-INJURIOUS IDEATION |
10 |
0.0024 |
| 47 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
10 |
0.0024 |
| 48 |
SOLILOQUY |
2 |
0.0023 |
| 49 |
SELF-DESTRUCTIVE BEHAVIOUR |
2 |
0.0023 |
| 50 |
REFLUX LARYNGITIS |
1 |
0.0023 |
| 51 |
TERMINAL INSOMNIA |
4 |
0.0023 |
| 52 |
HAEMORRHOID OPERATION |
1 |
0.0022 |
| 53 |
DELUSION OF GRANDEUR |
1 |
0.0022 |
| 54 |
PHONOPHOBIA |
1 |
0.0022 |
| 55 |
SEXUALLY INAPPROPRIATE BEHAVIOUR |
1 |
0.0021 |
| 56 |
WOLFF-PARKINSON-WHITE SYNDROME |
1 |
0.0021 |
| 57 |
PATIENT UNCOOPERATIVE |
1 |
0.0021 |
| 58 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
2 |
0.0021 |
| 59 |
HOMICIDAL IDEATION |
8 |
0.0020 |
| 60 |
HYPERMETABOLISM |
1 |
0.0019 |
| 61 |
EXECUTIVE DYSFUNCTION |
1 |
0.0018 |
| 62 |
NEAR DEATH EXPERIENCE |
6 |
0.0018 |
| 63 |
TRICHOTILLOMANIA |
1 |
0.0017 |
| 64 |
INTRUSIVE THOUGHTS |
2 |
0.0017 |
| 65 |
DERMATILLOMANIA |
1 |
0.0017 |
| 66 |
PALATAL DISORDER |
1 |
0.0017 |
| 67 |
SACRAL PAIN |
1 |
0.0016 |
| 68 |
THYROXINE DECREASED |
1 |
0.0016 |
| 69 |
SPONTANEOUS PENILE ERECTION |
1 |
0.0016 |
| 70 |
IMPULSIVE BEHAVIOUR |
6 |
0.0016 |
| 71 |
MANIA |
26 |
0.0016 |
| 72 |
ACTIVITIES OF DAILY LIVING DECREASED |
1 |
0.0016 |
| 73 |
SOCIAL ANXIETY DISORDER |
1 |
0.0015 |
| 74 |
HALLUCINATION, TACTILE |
1 |
0.0015 |
| 75 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
2 |
0.0015 |
| 76 |
IMPULSE-CONTROL DISORDER |
3 |
0.0015 |
| 77 |
TACHYPHRENIA |
5 |
0.0014 |
| 78 |
PHYSICAL ASSAULT |
3 |
0.0014 |
| 79 |
NONINFECTIVE ENCEPHALITIS |
1 |
0.0014 |
| 80 |
DISSOCIATIVE DISORDER |
1 |
0.0014 |
| 81 |
BITE |
1 |
0.0014 |
| 82 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
2 |
0.0014 |
| 83 |
WITHDRAWAL BLEED |
1 |
0.0014 |
| 84 |
WITHDRAWAL SYNDROME |
57 |
0.0014 |
| 85 |
BLUNTED AFFECT |
1 |
0.0014 |
| 86 |
HYPERACUSIS |
5 |
0.0013 |
| 87 |
INDIFFERENCE |
1 |
0.0013 |
| 88 |
ANGER |
44 |
0.0013 |
| 89 |
MIGRAINE |
124 |
0.0013 |
| 90 |
EYELID FUNCTION DISORDER |
1 |
0.0013 |
| 91 |
ORGASM ABNORMAL |
1 |
0.0012 |
| 92 |
BREATH ODOUR |
3 |
0.0012 |
| 93 |
EDUCATIONAL PROBLEM |
2 |
0.0012 |
| 94 |
INITIAL INSOMNIA |
12 |
0.0012 |
| 95 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
1 |
0.0011 |
| 96 |
TIC |
6 |
0.0011 |
| 97 |
PRODUCT AFTER TASTE |
1 |
0.0010 |
| 98 |
VOMITING PROJECTILE |
3 |
0.0010 |
| 99 |
NEGATIVE THOUGHTS |
3 |
0.0010 |
| 100 |
ENERGY INCREASED |
6 |
0.0010 |
| 101 |
ANTISOCIAL BEHAVIOUR |
1 |
0.0010 |
| 102 |
THYROID HORMONES INCREASED |
1 |
0.0010 |
| 103 |
TORTICOLLIS |
2 |
0.0009 |
| 104 |
BIPOLAR I DISORDER |
2 |
0.0009 |
| 105 |
MIDDLE EAR EFFUSION |
2 |
0.0009 |
| 106 |
SUICIDAL IDEATION |
82 |
0.0009 |
| 107 |
PRODUCT ADMINISTRATION INTERRUPTED |
7 |
0.0009 |
| 108 |
MOANING |
1 |
0.0009 |
| 109 |
METABOLIC SURGERY |
1 |
0.0009 |
| 110 |
MENOPAUSAL SYMPTOMS |
2 |
0.0009 |
| 111 |
MORBID THOUGHTS |
1 |
0.0009 |
| 112 |
FEELING OF BODY TEMPERATURE CHANGE |
5 |
0.0009 |
| 113 |
WRONG DOSE |
2 |
0.0008 |
| 114 |
HYPOMANIA |
3 |
0.0008 |
| 115 |
POST-ACUTE COVID-19 SYNDROME |
1 |
0.0008 |
| 116 |
VASODILATATION |
2 |
0.0008 |
| 117 |
YAWNING |
2 |
0.0007 |
| 118 |
PRODUCT SIZE ISSUE |
4 |
0.0007 |
| 119 |
GAMBLING DISORDER |
2 |
0.0007 |
| 120 |
IRRITABILITY |
44 |
0.0007 |
| 121 |
AFFECT LABILITY |
7 |
0.0007 |
| 122 |
DROOLING |
5 |
0.0007 |
| 123 |
INSURANCE ISSUE |
11 |
0.0007 |
| 124 |
ERECTION INCREASED |
3 |
0.0007 |
| 125 |
ELECTRIC SHOCK SENSATION |
2 |
0.0007 |
| 126 |
MAST CELL ACTIVATION SYNDROME |
1 |
0.0007 |
| 127 |
SLEEP TERROR |
3 |
0.0007 |
| 128 |
AUDITORY DISORDER |
1 |
0.0007 |
| 129 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
2 |
0.0007 |
| 130 |
ANKLE OPERATION |
1 |
0.0007 |
| 131 |
CONJUNCTIVITIS ALLERGIC |
1 |
0.0007 |
| 132 |
SKIN STRIAE |
1 |
0.0007 |
| 133 |
GASTRITIS HAEMORRHAGIC |
1 |
0.0007 |
| 134 |
DISSOCIATION |
5 |
0.0007 |
| 135 |
FEELING OF DESPAIR |
3 |
0.0006 |
| 136 |
MIDDLE INSOMNIA |
12 |
0.0006 |
| 137 |
TRANSCRIPTION MEDICATION ERROR |
1 |
0.0006 |
| 138 |
PRODUCT USE COMPLAINT |
10 |
0.0006 |
| 139 |
INAPPROPRIATE AFFECT |
1 |
0.0006 |
| 140 |
AGGRESSION |
31 |
0.0006 |
| 141 |
SHOULDER FRACTURE |
1 |
0.0006 |
| 142 |
DENTAL IMPLANTATION |
1 |
0.0006 |
| 143 |
THERAPY CHANGE |
6 |
0.0006 |
| 144 |
IMPAIRED WORK ABILITY |
13 |
0.0006 |
| 145 |
DRUG EFFECT LESS THAN EXPECTED |
9 |
0.0006 |
| 146 |
MENSTRUAL DISORDER |
5 |
0.0006 |
| 147 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 148 |
SLEEP TALKING |
1 |
0.0006 |
| 149 |
SKIN WOUND |
1 |
0.0006 |
| 150 |
EYE MOVEMENT DISORDER |
4 |
0.0006 |
| 151 |
TONGUE COATED |
1 |
0.0006 |
| 152 |
CATATONIA |
3 |
0.0006 |
| 153 |
EMOTIONAL POVERTY |
1 |
0.0006 |
| 154 |
PRODUCT COMMUNICATION ISSUE |
5 |
0.0006 |
| 155 |
HALLUCINATION, AUDITORY |
9 |
0.0006 |
| 156 |
PRODUCT DOSE OMISSION IN ERROR |
16 |
0.0006 |
| 157 |
RETCHING |
12 |
0.0006 |
| 158 |
SCHIZOAFFECTIVE DISORDER |
1 |
0.0006 |
| 159 |
BEHAVIOUR DISORDER |
3 |
0.0006 |
| 160 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 161 |
PUPILLARY REFLEX IMPAIRED |
1 |
0.0005 |
| 162 |
HEART RATE ABNORMAL |
3 |
0.0005 |
| 163 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 164 |
TUNNEL VISION |
1 |
0.0005 |
| 165 |
LIVING IN RESIDENTIAL INSTITUTION |
1 |
0.0005 |
| 166 |
PHOTOPHOBIA |
10 |
0.0005 |
| 167 |
CRYING |
19 |
0.0005 |
| 168 |
NIGHTMARE |
18 |
0.0005 |
| 169 |
CONVERSION DISORDER |
1 |
0.0005 |
| 170 |
NASAL SEPTUM DEVIATION |
1 |
0.0005 |
| 171 |
UNDERWEIGHT |
1 |
0.0005 |
| 172 |
INABILITY TO AFFORD MEDICATION |
5 |
0.0005 |
| 173 |
ENURESIS |
2 |
0.0005 |
| 174 |
LIBIDO INCREASED |
1 |
0.0005 |
| 175 |
EYELID PAIN |
1 |
0.0005 |
| 176 |
SELF-MEDICATION |
2 |
0.0005 |
| 177 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
1 |
0.0005 |
| 178 |
PSYCHOMOTOR HYPERACTIVITY |
8 |
0.0005 |
| 179 |
HALLUCINATIONS, MIXED |
2 |
0.0005 |
| 180 |
MOOD SWINGS |
15 |
0.0005 |
| 181 |
INCORRECT DRUG ADMINISTRATION RATE |
2 |
0.0005 |
| 182 |
THERAPY CESSATION |
24 |
0.0005 |
| 183 |
PANIC ATTACK |
17 |
0.0005 |
| 184 |
TEARFULNESS |
2 |
0.0005 |
| 185 |
OLIGOMENORRHOEA |
1 |
0.0005 |
| 186 |
CORNEAL DISORDER |
1 |
0.0005 |
| 187 |
DELUSION |
7 |
0.0005 |
| 188 |
FEAR OF DEATH |
1 |
0.0004 |
| 189 |
GASTROINTESTINAL HYPOMOTILITY |
1 |
0.0004 |
| 190 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
2 |
0.0004 |
| 191 |
REACTION TO EXCIPIENT |
1 |
0.0004 |
| 192 |
SOMNOLENCE |
87 |
0.0004 |
| 193 |
FLAT AFFECT |
1 |
0.0004 |
| 194 |
RENAL FUNCTION TEST ABNORMAL |
2 |
0.0004 |
| 195 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
1 |
0.0004 |
| 196 |
DYSMORPHISM |
1 |
0.0004 |
| 197 |
EMOTIONAL DISORDER |
13 |
0.0004 |
| 198 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 199 |
FEELING JITTERY |
8 |
0.0004 |
| 200 |
URINARY HESITATION |
1 |
0.0004 |
| 201 |
SEROTONIN SYNDROME |
8 |
0.0004 |
| 202 |
APATHY |
6 |
0.0004 |
| 203 |
INSOMNIA |
109 |
0.0004 |
| 204 |
PARANOIA |
7 |
0.0004 |
| 205 |
ABNORMAL BEHAVIOUR |
16 |
0.0004 |
| 206 |
ADVERSE EVENT |
36 |
0.0004 |
| 207 |
ABNORMAL UTERINE BLEEDING |
1 |
0.0004 |
| 208 |
MENOPAUSE |
1 |
0.0004 |
| 209 |
DRUG TITRATION ERROR |
1 |
0.0004 |
| 210 |
CATHETER SITE PAIN |
1 |
0.0004 |
| 211 |
AFFECTIVE DISORDER |
3 |
0.0004 |
| 212 |
CYANOSIS |
6 |
0.0004 |
| 213 |
PRODUCT RESIDUE PRESENT |
2 |
0.0004 |
| 214 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 215 |
EAR CONGESTION |
1 |
0.0004 |
| 216 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 217 |
MIGRAINE WITH AURA |
1 |
0.0004 |
| 218 |
NONSPECIFIC REACTION |
2 |
0.0004 |
| 219 |
CYSTIC FIBROSIS |
2 |
0.0004 |
| 220 |
ANTIPSYCHOTIC DRUG LEVEL INCREASED |
1 |
0.0004 |
| 221 |
AGITATION |
26 |
0.0004 |
| 222 |
CEREBRAL THROMBOSIS |
1 |
0.0004 |
| 223 |
THERAPY INTERRUPTED |
25 |
0.0003 |
| 224 |
HYPERTONIC BLADDER |
1 |
0.0003 |
| 225 |
SOCIAL AVOIDANT BEHAVIOUR |
2 |
0.0003 |
| 226 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 227 |
HYPERVENTILATION |
2 |
0.0003 |
| 228 |
URINE ODOUR ABNORMAL |
2 |
0.0003 |
| 229 |
URINE ANALYSIS ABNORMAL |
1 |
0.0003 |
| 230 |
HEART RATE INCREASED |
33 |
0.0003 |
| 231 |
LOSS OF EMPLOYMENT |
1 |
0.0003 |
| 232 |
MOOD ALTERED |
9 |
0.0003 |
| 233 |
DYSCHEZIA |
1 |
0.0003 |
| 234 |
THINKING ABNORMAL |
6 |
0.0003 |
| 235 |
SCREAMING |
2 |
0.0003 |
| 236 |
HYPERSOMNIA |
9 |
0.0003 |
| 237 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 238 |
CUSHINGOID |
1 |
0.0003 |
| 239 |
VULVOVAGINAL DRYNESS |
1 |
0.0003 |
| 240 |
BRADYPHRENIA |
2 |
0.0003 |
| 241 |
LIGAMENT SPRAIN |
3 |
0.0003 |
| 242 |
SKIN INJURY |
1 |
0.0003 |
| 243 |
POTENTIATING DRUG INTERACTION |
1 |
0.0003 |
| 244 |
SLUGGISHNESS |
3 |
0.0003 |
| 245 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
14 |
0.0003 |
| 246 |
PRIAPISM |
1 |
0.0003 |
| 247 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
1 |
0.0003 |
| 248 |
EXTRASYSTOLES |
2 |
0.0003 |
| 249 |
PRODUCT ODOUR ABNORMAL |
3 |
0.0003 |
| 250 |
DEPRESSIVE SYMPTOM |
1 |
0.0003 |
| 251 |
DRY MOUTH |
23 |
0.0003 |
| 252 |
VOMITING |
132 |
0.0003 |
| 253 |
APPENDICECTOMY |
1 |
0.0003 |
| 254 |
PARALYSIS |
4 |
0.0003 |
| 255 |
DECREASED ACTIVITY |
3 |
0.0003 |
| 256 |
PANIC REACTION |
2 |
0.0003 |
| 257 |
MAJOR DEPRESSION |
2 |
0.0003 |
| 258 |
FOOD INTOLERANCE |
1 |
0.0003 |
| 259 |
ERECTILE DYSFUNCTION |
7 |
0.0003 |
| 260 |
PARADOXICAL DRUG REACTION |
1 |
0.0003 |
| 261 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
| 262 |
PSYCHOTIC DISORDER |
8 |
0.0003 |
| 263 |
FEELING DRUNK |
2 |
0.0003 |
| 264 |
HALLUCINATION |
20 |
0.0003 |
| 265 |
SNORING |
1 |
0.0003 |
| 266 |
BOWEL MOVEMENT IRREGULARITY |
2 |
0.0003 |
| 267 |
LETHARGY |
15 |
0.0003 |
| 268 |
THERAPEUTIC PRODUCT INEFFECTIVE |
1 |
0.0003 |
| 269 |
DYSTONIA |
5 |
0.0003 |
| 270 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 271 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 272 |
HEART RATE DECREASED |
9 |
0.0003 |
| 273 |
SEXUAL DYSFUNCTION |
3 |
0.0003 |
| 274 |
BRAIN FOG |
4 |
0.0003 |
| 275 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 276 |
HYPERPHAGIA |
1 |
0.0003 |
| 277 |
OBSESSIVE-COMPULSIVE DISORDER |
2 |
0.0002 |
| 278 |
INTENTIONAL SELF-INJURY |
5 |
0.0002 |
| 279 |
FRUSTRATION TOLERANCE DECREASED |
2 |
0.0002 |
| 280 |
ADVERSE DRUG REACTION |
22 |
0.0002 |
| 281 |
POLYURIA |
2 |
0.0002 |
| 282 |
HYPERAESTHESIA |
2 |
0.0002 |
| 283 |
PHOTOSENSITIVITY REACTION |
4 |
0.0002 |
| 284 |
SOCIAL PROBLEM |
1 |
0.0002 |
| 285 |
MYDRIASIS |
3 |
0.0002 |
| 286 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 287 |
HEADACHE |
146 |
0.0002 |
| 288 |
TENSION HEADACHE |
1 |
0.0002 |
| 289 |
PULMONARY FUNCTION TEST DECREASED |
1 |
0.0002 |
| 290 |
BEDRIDDEN |
3 |
0.0002 |
| 291 |
DEPRESSED MOOD |
12 |
0.0002 |
| 292 |
COLD SWEAT |
4 |
0.0002 |
| 293 |
HEAD DISCOMFORT |
4 |
0.0002 |
| 294 |
SEIZURE |
26 |
0.0002 |
| 295 |
FEAR |
6 |
0.0002 |
| 296 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 297 |
PRODUCT AVAILABILITY ISSUE |
5 |
0.0002 |
| 298 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
0.0002 |
| 299 |
ABNORMAL DREAMS |
6 |
0.0002 |
| 300 |
EYE OPERATION |
1 |
0.0002 |
| 301 |
PERSONALITY CHANGE |
2 |
0.0002 |
| 302 |
ROSACEA |
1 |
0.0002 |
| 303 |
SKIN ABRASION |
1 |
0.0002 |
| 304 |
PRODUCT PACKAGING ISSUE |
2 |
0.0002 |
| 305 |
PULSE ABSENT |
1 |
0.0002 |
| 306 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 307 |
RASH VESICULAR |
1 |
0.0002 |
| 308 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 309 |
SLEEP DISORDER |
14 |
0.0002 |
| 310 |
DEPRESSION |
45 |
0.0002 |
| 311 |
DYSPHORIA |
1 |
0.0002 |
| 312 |
CORONARY ARTERIAL STENT INSERTION |
1 |
0.0002 |
| 313 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
14 |
0.0002 |
| 314 |
ANXIETY |
56 |
0.0002 |
| 315 |
DRUG DELIVERY SYSTEM MALFUNCTION |
1 |
0.0002 |
| 316 |
EUPHORIC MOOD |
2 |
0.0002 |
| 317 |
TRISMUS |
1 |
0.0002 |
| 318 |
HALLUCINATION, VISUAL |
4 |
0.0002 |
| 319 |
OVERWEIGHT |
1 |
0.0002 |
| 320 |
BRUXISM |
1 |
0.0002 |
| 321 |
ASTHENOPIA |
1 |
0.0002 |
| 322 |
AUTISM SPECTRUM DISORDER |
1 |
0.0002 |
| 323 |
GENERALISED TONIC-CLONIC SEIZURE |
3 |
0.0002 |
| 324 |
THERAPEUTIC RESPONSE SHORTENED |
6 |
0.0002 |
| 325 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 326 |
DRY EYE |
9 |
0.0002 |
| 327 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 328 |
CHILLS |
21 |
0.0002 |
| 329 |
INTERMENSTRUAL BLEEDING |
1 |
0.0002 |
| 330 |
THERAPY NON-RESPONDER |
8 |
0.0002 |
| 331 |
IMPAIRED DRIVING ABILITY |
2 |
0.0002 |
| 332 |
SCAB |
2 |
0.0002 |
| 333 |
MUSCLE TWITCHING |
4 |
0.0002 |
| 334 |
PRODUCT DOSE OMISSION ISSUE |
51 |
0.0002 |
| 335 |
SKIN WARM |
1 |
0.0002 |
| 336 |
AMENORRHOEA |
3 |
0.0002 |
| 337 |
DECREASED INTEREST |
1 |
0.0002 |
| 338 |
BRADYKINESIA |
1 |
0.0002 |
| 339 |
SINUS HEADACHE |
1 |
0.0002 |
| 340 |
ODYNOPHAGIA |
1 |
0.0002 |
| 341 |
SYMPTOM RECURRENCE |
1 |
0.0002 |
| 342 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 343 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 344 |
NAUSEA |
130 |
0.0002 |
| 345 |
DRUG WITHDRAWAL SYNDROME |
14 |
0.0002 |
| 346 |
THERAPEUTIC RESPONSE CHANGED |
1 |
0.0002 |
| 347 |
DRUG INTERACTION |
25 |
0.0002 |
| 348 |
GALACTORRHOEA |
1 |
0.0002 |
| 349 |
ILLNESS |
16 |
0.0002 |
| 350 |
HEPATITIS ACUTE |
1 |
0.0002 |
| 351 |
SEDATION |
4 |
0.0002 |
| 352 |
SPEECH DISORDER |
8 |
0.0002 |
| 353 |
SOMNAMBULISM |
1 |
0.0002 |
| 354 |
SINUS DISORDER |
3 |
0.0002 |
| 355 |
CONSTIPATION |
33 |
0.0002 |
| 356 |
APPETITE DISORDER |
1 |
0.0002 |
| 357 |
ADVERSE REACTION |
2 |
0.0002 |
| 358 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 359 |
PRODUCT PHYSICAL ISSUE |
3 |
0.0001 |
| 360 |
SINUS CONGESTION |
2 |
0.0001 |
| 361 |
PRODUCT TASTE ABNORMAL |
2 |
0.0001 |
| 362 |
HYPERHIDROSIS |
19 |
0.0001 |
| 363 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 364 |
IMPAIRED GASTRIC EMPTYING |
2 |
0.0001 |
| 365 |
AKATHISIA |
2 |
0.0001 |
| 366 |
DEVICE MECHANICAL ISSUE |
2 |
0.0001 |
| 367 |
GASTROINTESTINAL DISORDER |
13 |
0.0001 |
| 368 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 369 |
BLOOD PRESSURE INCREASED |
22 |
0.0001 |
| 370 |
FORMICATION |
1 |
0.0001 |
| 371 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 372 |
HAND FRACTURE |
1 |
0.0001 |
| 373 |
EATING DISORDER |
3 |
0.0001 |
| 374 |
INTENTIONAL DOSE OMISSION |
4 |
0.0001 |
| 375 |
FATIGUE |
109 |
0.0001 |
| 376 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 377 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 378 |
MENTAL DISORDER |
6 |
0.0001 |
| 379 |
FEELING ABNORMAL |
33 |
0.0001 |
| 380 |
FAECES SOFT |
1 |
0.0001 |
| 381 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 382 |
GASTROOESOPHAGEAL REFLUX DISEASE |
11 |
0.0001 |
| 383 |
PSYCHIATRIC SYMPTOM |
1 |
0.0001 |
| 384 |
TACHYCARDIA |
12 |
0.0001 |
| 385 |
SKIN HAEMORRHAGE |
2 |
0.0001 |
| 386 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
6 |
0.0001 |
| 387 |
DECREASED APPETITE |
31 |
0.0001 |
| 388 |
PRODUCT USE ISSUE |
25 |
0.0001 |
| 389 |
TINNITUS |
6 |
0.0001 |
| 390 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 391 |
DISTURBANCE IN ATTENTION |
7 |
0.0001 |
| 392 |
FOOD ALLERGY |
1 |
0.0001 |
| 393 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 394 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 395 |
SENSORY DISTURBANCE |
2 |
0.0001 |
| 396 |
NIGHT SWEATS |
4 |
0.0001 |
| 397 |
MENTAL IMPAIRMENT |
3 |
0.0001 |
| 398 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 399 |
DYSKINESIA |
5 |
0.0001 |
| 400 |
SUBSTANCE ABUSE |
1 |
0.0001 |
| 401 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 402 |
HOT FLUSH |
9 |
0.0001 |
| 403 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 404 |
INADEQUATE ANALGESIA |
1 |
0.0001 |
| 405 |
HYPOPHAGIA |
3 |
0.0001 |
| 406 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 407 |
CARDIAC OPERATION |
1 |
0.0001 |
| 408 |
MUSCLE STRAIN |
1 |
0.0001 |
| 409 |
HYSTERECTOMY |
1 |
0.0001 |
| 410 |
TREMOR |
19 |
0.0001 |
| 411 |
THIRST |
2 |
0.0001 |
| 412 |
LOSS OF LIBIDO |
1 |
0.0001 |
| 413 |
PALPITATIONS |
13 |
0.0001 |
| 414 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 415 |
RESTLESSNESS |
4 |
0.0001 |
| 416 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 417 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 418 |
GASTRIC ULCER |
2 |
0.0001 |
| 419 |
INCREASED APPETITE |
2 |
0.0001 |
| 420 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 421 |
BLOOD GLUCOSE DECREASED |
5 |
0.0001 |
| 422 |
LOWER LIMB FRACTURE |
2 |
0.0001 |
| 423 |
ERUCTATION |
2 |
0.0001 |
| 424 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 425 |
DYSSTASIA |
3 |
0.0001 |
| 426 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 427 |
SKIN FISSURES |
2 |
0.0001 |
| 428 |
COELIAC DISEASE |
1 |
0.0001 |
| 429 |
LOSS OF CONSCIOUSNESS |
13 |
0.0001 |
| 430 |
OVARIAN CYST |
1 |
0.0001 |
| 431 |
APHASIA |
3 |
0.0001 |
| 432 |
TASTE DISORDER |
2 |
0.0001 |
| 433 |
EYELID PTOSIS |
1 |
0.0001 |
| 434 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 435 |
FEELING HOT |
6 |
0.0001 |
| 436 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 437 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 438 |
TENDERNESS |
1 |
0.0001 |
| 439 |
POLLAKIURIA |
4 |
0.0001 |
| 440 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 441 |
SCRATCH |
1 |
0.0001 |
| 442 |
INCONTINENCE |
1 |
0.0001 |
| 443 |
RENAL PAIN |
1 |
0.0001 |
| 444 |
HYPOTHYROIDISM |
3 |
0.0001 |
| 445 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 446 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 447 |
MENSTRUATION DELAYED |
1 |
0.0001 |
| 448 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 449 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 450 |
VIRAL INFECTION |
3 |
0.0001 |
| 451 |
GAIT INABILITY |
3 |
0.0001 |
| 452 |
MALNUTRITION |
1 |
0.0001 |
| 453 |
SNEEZING |
2 |
0.0001 |
| 454 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 455 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 456 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 457 |
DIZZINESS |
44 |
0.0001 |
| 458 |
CHEST DISCOMFORT |
9 |
0.0001 |
| 459 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 460 |
ABDOMINAL PAIN UPPER |
18 |
0.0001 |
| 461 |
SKIN IRRITATION |
4 |
0.0001 |
| 462 |
SUICIDE ATTEMPT |
5 |
0.0001 |
| 463 |
BURSITIS |
1 |
0.0001 |
| 464 |
NOCTURIA |
1 |
0.0001 |
| 465 |
PRESYNCOPE |
2 |
0.0001 |
| 466 |
VERTIGO |
5 |
0.0001 |
| 467 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 468 |
ILEUS |
1 |
0.0001 |
| 469 |
VISION BLURRED |
11 |
0.0001 |
| 470 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 471 |
POISONING |
1 |
0.0001 |
| 472 |
CONDITION AGGRAVATED |
24 |
0.0001 |
| 473 |
PRODUCT COMPLAINT |
2 |
0.0001 |
| 474 |
HAEMATEMESIS |
2 |
0.0001 |
| 475 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 476 |
ECZEMA |
4 |
0.0001 |
| 477 |
ANHEDONIA |
2 |
0.0001 |
| 478 |
DISORIENTATION |
3 |
0.0001 |
| 479 |
WEIGHT DECREASED |
21 |
0.0001 |
| 480 |
DEHYDRATION |
10 |
0.0001 |
| 481 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 482 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 483 |
SKIN LESION |
2 |
0.0001 |
| 484 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 485 |
COMPLETED SUICIDE |
6 |
0.0001 |
| 486 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 487 |
FEELING COLD |
2 |
0.0001 |
| 488 |
HUNGER |
1 |
0.0001 |
| 489 |
ABDOMINAL DISCOMFORT |
12 |
0.0001 |
| 490 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 491 |
DYSPEPSIA |
7 |
0.0001 |
| 492 |
PAIN IN JAW |
2 |
0.0001 |
| 493 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 494 |
HYPOKINESIA |
1 |
0.0001 |
| 495 |
GASTROENTERITIS |
1 |
0.0001 |
| 496 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 497 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 498 |
EPISTAXIS |
5 |
0.0001 |
| 499 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 500 |
CONTRAINDICATED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 501 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 502 |
ILL-DEFINED DISORDER |
4 |
0.0001 |
| 503 |
PRODUCT USE IN UNAPPROVED INDICATION |
16 |
0.0001 |
| 504 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 505 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 506 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 507 |
DRUG INEFFECTIVE |
82 |
0.0001 |
| 508 |
CARDIAC ARREST |
5 |
0.0001 |
| 509 |
BLOOD PRESSURE DECREASED |
4 |
0.0001 |
| 510 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 511 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 512 |
SCAR |
1 |
0.0001 |
| 513 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 514 |
MEMORY IMPAIRMENT |
8 |
0.0001 |
| 515 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 516 |
DELIRIUM |
2 |
0.0001 |
| 517 |
DEVICE USE ERROR |
2 |
0.0001 |
| 518 |
ABDOMINAL DISTENSION |
6 |
0.0001 |
| 519 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 520 |
RASH MACULAR |
2 |
0.0001 |
| 521 |
BRADYCARDIA |
3 |
0.0001 |
| 522 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 523 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 524 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 525 |
TOOTHACHE |
1 |
0.0001 |
| 526 |
PELVIC PAIN |
1 |
0.0001 |
| 527 |
HYPOTENSION |
11 |
0.0001 |
| 528 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 529 |
BRONCHITIS |
4 |
0.0001 |
| 530 |
CHEST PAIN |
10 |
0.0001 |
| 531 |
NECK PAIN |
3 |
0.0001 |
| 532 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 533 |
DRY SKIN |
7 |
0.0001 |
| 534 |
DRUG INTOLERANCE |
5 |
0.0001 |
| 535 |
CHOKING |
1 |
0.0001 |
| 536 |
DRUG DOSE OMISSION BY DEVICE |
4 |
0.0001 |
| 537 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 538 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 539 |
SYNCOPE |
5 |
0.0000 |
| 540 |
PREGNANCY |
1 |
0.0000 |
| 541 |
DEVICE BREAKAGE |
2 |
0.0000 |
| 542 |
WEIGHT INCREASED |
11 |
0.0000 |
| 543 |
MUSCLE SPASMS |
9 |
0.0000 |
| 544 |
INFLUENZA LIKE ILLNESS |
4 |
0.0000 |
| 545 |
MOUTH ULCERATION |
1 |
0.0000 |
| 546 |
URINARY TRACT INFECTION |
8 |
0.0000 |
| 547 |
JOINT INJURY |
1 |
0.0000 |
| 548 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 549 |
DEVICE LEAKAGE |
2 |
0.0000 |
| 550 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 551 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 552 |
RASH |
20 |
0.0000 |
| 553 |
MALAISE |
20 |
0.0000 |
| 554 |
ASTHENIA |
17 |
0.0000 |
| 555 |
PARAESTHESIA |
7 |
0.0000 |
| 556 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
9 |
0.0000 |
| 557 |
PAIN |
27 |
0.0000 |
| 558 |
RENAL DISORDER |
2 |
0.0000 |
| 559 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 560 |
HYPERTENSION |
9 |
0.0000 |
| 561 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 562 |
GAIT DISTURBANCE |
8 |
0.0000 |
| 563 |
URTICARIA |
7 |
0.0000 |
| 564 |
PRURITUS |
16 |
0.0000 |
| 565 |
LOCALISED INFECTION |
1 |
0.0000 |
| 566 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 567 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 568 |
HOSPITALISATION |
6 |
0.0000 |
| 569 |
SINUSITIS |
4 |
0.0000 |
| 570 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 571 |
DIARRHOEA |
25 |
0.0000 |
| 572 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 573 |
DIPLOPIA |
1 |
0.0000 |
| 574 |
GASTRITIS |
1 |
0.0000 |
| 575 |
DERMATITIS ATOPIC |
2 |
0.0000 |
| 576 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 577 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 578 |
PALLOR |
1 |
0.0000 |
| 579 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 580 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 581 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 582 |
HYPONATRAEMIA |
2 |
0.0000 |
| 583 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 584 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 585 |
BACK PAIN |
8 |
0.0000 |
| 586 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 587 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 588 |
COVID-19 |
6 |
0.0000 |
| 589 |
DYSPHONIA |
2 |
0.0000 |
| 590 |
SURGERY |
2 |
0.0000 |
| 591 |
RENAL INJURY |
1 |
0.0000 |
| 592 |
HYPOAESTHESIA |
5 |
0.0000 |
| 593 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 594 |
HEPATIC FAILURE |
1 |
0.0000 |
| 595 |
DISCOMFORT |
2 |
0.0000 |
| 596 |
EPILEPSY |
1 |
0.0000 |
| 597 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 598 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 599 |
VISUAL IMPAIRMENT |
4 |
0.0000 |
| 600 |
DYSPNOEA |
18 |
0.0000 |
| 601 |
HEAD INJURY |
1 |
0.0000 |
| 602 |
AMNESIA |
2 |
0.0000 |
| 603 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 604 |
ABDOMINAL PAIN |
7 |
0.0000 |
| 605 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 606 |
SKIN DISORDER |
1 |
0.0000 |
| 607 |
URINARY RETENTION |
1 |
0.0000 |
| 608 |
EYE PRURITUS |
1 |
0.0000 |
| 609 |
FLUSHING |
3 |
0.0000 |
| 610 |
PYREXIA |
10 |
0.0000 |
| 611 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 612 |
MOBILITY DECREASED |
2 |
0.0000 |
| 613 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 614 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 615 |
DYSURIA |
1 |
0.0000 |
| 616 |
NASOPHARYNGITIS |
5 |
0.0000 |
| 617 |
HYPERSENSITIVITY |
5 |
0.0000 |
| 618 |
INFLUENZA |
3 |
0.0000 |
| 619 |
EYE SWELLING |
1 |
0.0000 |
| 620 |
DYSARTHRIA |
1 |
0.0000 |
| 621 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 622 |
OFF LABEL USE |
23 |
0.0000 |
| 623 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 624 |
INJECTION SITE PAIN |
8 |
0.0000 |
| 625 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 626 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 627 |
INJECTION SITE HAEMORRHAGE |
2 |
0.0000 |
| 628 |
CARDIAC FAILURE |
2 |
0.0000 |
| 629 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 630 |
TREATMENT FAILURE |
2 |
0.0000 |
| 631 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 632 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 633 |
MYALGIA |
4 |
0.0000 |
| 634 |
HYPOACUSIS |
1 |
0.0000 |
| 635 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 636 |
SEPTIC SHOCK |
1 |
0.0000 |
| 637 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 638 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 639 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 640 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 641 |
ARTHRALGIA |
9 |
0.0000 |
| 642 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 643 |
SWELLING |
2 |
0.0000 |
| 644 |
DYSPHAGIA |
2 |
0.0000 |
| 645 |
COMA |
1 |
0.0000 |
| 646 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 647 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 648 |
LUNG DISORDER |
1 |
0.0000 |
| 649 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 650 |
INFLAMMATION |
1 |
0.0000 |
| 651 |
NERVOUSNESS |
1 |
0.0000 |
| 652 |
RASH PRURITIC |
1 |
0.0000 |
| 653 |
DEPENDENCE |
1 |
0.0000 |
| 654 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 655 |
COUGH |
5 |
0.0000 |
| 656 |
EYE PAIN |
1 |
0.0000 |
| 657 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 658 |
ASTHMA |
2 |
0.0000 |
| 659 |
FLATULENCE |
1 |
0.0000 |
| 660 |
EYE IRRITATION |
1 |
0.0000 |
| 661 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 662 |
CATARACT |
1 |
0.0000 |
| 663 |
NO ADVERSE EVENT |
3 |
0.0000 |
| 664 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 665 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 666 |
RHINORRHOEA |
1 |
0.0000 |
| 667 |
ALOPECIA |
3 |
0.0000 |
| 668 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 669 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 670 |
BURNING SENSATION |
1 |
0.0000 |
| 671 |
INJURY |
1 |
0.0000 |
| 672 |
INFECTION |
2 |
0.0000 |
| 673 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 674 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 675 |
DRUG DEPENDENCE |
2 |
0.0000 |
| 676 |
FALL |
4 |
0.0000 |
| 677 |
DRUG ABUSE |
1 |
0.0000 |
| 678 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 679 |
BALANCE DISORDER |
1 |
0.0000 |
| 680 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 681 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 682 |
CARDIAC DISORDER |
1 |
0.0000 |
| 683 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 684 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 685 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 686 |
ERYTHEMA |
2 |
0.0000 |
| 687 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 688 |
HAEMORRHAGE |
1 |
0.0000 |
| 689 |
OVERDOSE |
2 |
0.0000 |
| 690 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 691 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 692 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 693 |
JOINT SWELLING |
1 |
0.0000 |
| 694 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 695 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 696 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 697 |
ANAEMIA |
1 |
0.0000 |
| 698 |
DEATH |
2 |
0.0000 |